| Hereditary Malignant Urinary System Neoplasm studied in …STUDIED_INderived13 of 13show fewer |
|---|
| → studied in | NCT04981509Phase 2 · recruiting Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer · condition mapped ONTOLOGY_EXACT · 13 trials mapped (7 active) | — | — | Hereditary Leiomyomatosis and Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001238recruiting Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders · condition mapped ALIAS · 13 trials mapped (7 active) | — | — | Hereditary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07716735Phase 1 · not yet recruiting Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer · condition mapped ONTOLOGY_EXACT · 13 trials mapped (7 active) | — | — | Hereditary Leiomyomatosis and Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07300241Phase 1 · recruiting Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma · condition mapped ALIAS · 13 trials mapped (7 active) | — | — | Von Hippel Lindau Syndrome-Associated Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03401788Phase 2 · active not recruiting A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004) · condition mapped ALIAS · 13 trials mapped (7 active) | — | — | Von Hippel Lindau Syndrome-Associated Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04623502NA · recruiting An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy · condition mapped ALIAS · 13 trials mapped (7 active) | — | — | Hereditary Leiomyomatosis and Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01130519Phase 2 · completed A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer · condition mapped ALIAS · 13 trials mapped (7 active) | — | — | Hereditary Leiomyomatosis and Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03749980recruiting MyVHL: Patient Natural History Study · condition mapped ALIAS · 13 trials mapped (7 active) | — | — | Hereditary Leiomyomatosis and Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05534854unknown Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes · condition mapped ALIAS · 13 trials mapped (7 active) | — | — | Hereditary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04603365Phase 2 · withdrawn Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer · condition mapped ONTOLOGY_EXACT · 13 trials mapped (7 active) | — | — | Hereditary Leiomyomatosis and Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00727532NA · terminated Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 13 trials mapped (7 active) | — | — | Hereditary Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00971620Phase 2 · completed Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin · condition mapped ALIAS · 13 trials mapped (7 active) | — | — | Hereditary Leiomyomatosis and Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01353300completed Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer · condition mapped ALIAS · 13 trials mapped (7 active) | — | — | Hereditary Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |